PLoS Pathogens (Jun 2015)

Complement-Opsonized HIV-1 Overcomes Restriction in Dendritic Cells.

  • Wilfried Posch,
  • Marion Steger,
  • Ulla Knackmuss,
  • Michael Blatzer,
  • Hanna-Mari Baldauf,
  • Wolfgang Doppler,
  • Tommy E White,
  • Paul Hörtnagl,
  • Felipe Diaz-Griffero,
  • Cornelia Lass-Flörl,
  • Hubert Hackl,
  • Arnaud Moris,
  • Oliver T Keppler,
  • Doris Wilflingseder

DOI
https://doi.org/10.1371/journal.ppat.1005005
Journal volume & issue
Vol. 11, no. 6
p. e1005005

Abstract

Read online

DCs express intrinsic cellular defense mechanisms to specifically inhibit HIV-1 replication. Thus, DCs are productively infected only at very low levels with HIV-1, and this non-permissiveness of DCs is suggested to go along with viral evasion. We now illustrate that complement-opsonized HIV-1 (HIV-C) efficiently bypasses SAMHD1 restriction and productively infects DCs including BDCA-1 DCs. Efficient DC infection by HIV-C was also observed using single-cycle HIV-C, and correlated with a remarkable elevated SAMHD1 T592 phosphorylation but not SAMHD1 degradation. If SAMHD1 phosphorylation was blocked using a CDK2-inhibitor HIV-C-induced DC infection was also significantly abrogated. Additionally, we found a higher maturation and co-stimulatory potential, aberrant type I interferon expression and signaling as well as a stronger induction of cellular immune responses in HIV-C-treated DCs. Collectively, our data highlight a novel protective mechanism mediated by complement opsonization of HIV to effectively promote DC immune functions, which might be in the future exploited to tackle HIV infection.